Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)

Grants

Funding Acknowledgements

Professor Hicks was the recipient of a translational research grant from the Victorian Cancer Agency, which supported establishment of a prospective database of all patients referred for PRRT. The authors would like to thank the patients, their families and our referring doctors for their trust in and support of our programme, the Unicorn Foundation for its advocacy for NET patients and our NET nurses for their diligence and care of our patients.